1. Home
  2. BCRX vs IMKTA Comparison

BCRX vs IMKTA Comparison

Compare BCRX & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.20

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

N/A

Current Price

$83.98

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
BCRX
IMKTA
Founded
1986
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
BCRX
IMKTA
Price
$7.20
$83.98
Analyst Decision
Buy
Analyst Count
11
0
Target Price
★ $20.45
N/A
AVG Volume (30 Days)
★ 4.5M
63.9K
Earning Date
11-04-2026
11-30-2026
Dividend Yield
N/A
★ 0.78%
EPS Growth
★ 381.40
N/A
EPS
N/A
★ N/A
Revenue
$25,186,000.00
★ $5,334,032,609.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.71
N/A
P/E Ratio
★ N/A
$15.91
Revenue Growth
★ N/A
N/A
52 Week Low
$6.23
$67.92
52 Week High
$11.22
$95.62

Technical Indicators

Market Signals
Indicator
BCRX
IMKTA
Relative Strength Index (RSI) 35.29 46.77
Support Level N/A $82.10
Resistance Level $8.83 $84.55
Average True Range (ATR) 0.37 2.03
MACD -0.05 0.01
Stochastic Oscillator 0.87 35.55

Price Performance

Historical Comparison
BCRX
IMKTA

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: